Dr. Chaudhary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
# Hematolo
Milwaukee, WI 53226Phone+1 414-805-6800Fax+1 414-805-4944
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2013 - 2015
- West Virginia UniversityFellowship, Hematology and Medical Oncology, 2012 - 2013
- West Virginia UniversityResidency, Internal Medicine, 2009 - 2012
- King Edward Medical UniversityClass of 2005
Certifications & Licensure
- WI State Medical License 2013 - 2025
- WV State Medical License 2012 - 2014
Clinical Trials
- Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer Start of enrollment: 2024 Aug 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemothera...Jayasree Krishnan, Archit Patel, Arya Mariam Roy, Malak Alharbi, Ankita Kapoor
Clinical Breast Cancer. 2024-12-01 - Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.Sabah Alaklabi, Arya Mariam Roy, Paola Zagami, Anumita Chakraborty, Nicole Held
JCO Oncology Practice. 2024-10-01 - Evaluating the Accuracy, Quality, and Readability of Online Breast Cancer Information.Elsie A Valencia, Chandler S Cortina, Adrienne N Cobb, Lubna N Chaudhary, Tracy Kelly
Annals of Surgery Open. 2024-09-01
Press Mentions
- Data Continue to Help Shape CDK4/6 Inhibitor Selection, Sequencing in HR+ Breast CancerDecember 7th, 2024
- Medical College of Wisconsin Scientists Find New Marker That Predicts Early Recurrence of Breast CancerJanuary 25th, 2023
- Medical College of Wisconsin Scientists Find New Marker That Predicts Early Recurrence of Breast CancerJanuary 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: